Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies
Clinical studies of cell-based immunotherapies have included both patient-specific (autologous) and non-patient-specific (allogeneic) approaches. Major concerns in using allogeneic immunotherapies are that the induced immune responses may be predominantly directed against the allogeneic HLA molecule...
Description complète
Détails bibliographiques
| Publié dans: | Clinical immunology (Orlando, Fla.). - 1999. - 133(2009), 2 vom: 14. Nov., Seite 184-97
|
|---|
| Auteur principal: |
Li, Betty
(Auteur) |
|---|
| Autres auteurs: |
Simmons, Andrew,
Du, Thomas,
Lin, Carol,
Moskalenko, Marina,
Gonzalez-Edick, Melissa,
VanRoey, Melinda,
Jooss, Karin |
|---|
| Format: | Article en ligne
|
|---|
| Langue: | English |
|---|
| Publié: |
2009
|
|---|
| Accès à la collection: | Clinical immunology (Orlando, Fla.)
|
|---|
| Sujets: | Journal Article
Cancer Vaccines
Cytokines
Histocompatibility Antigens Class I
OVA-8
Peptide Fragments
Granulocyte-Macrophage Colony-Stimulating Factor
83869-56-1
Ovalbumin
9006-59-1 |
|---|